إسرائيل - العبرية - Ministry of Health

נובוגולד בע"מ - רופא - משתלי סיליקון ונילווים

إسرائيل - العبرية - Ministry of Health

kamada ltd, israel - plasma protein fraction - תמיסה לאינפוזיה - plasma protein fraction 200 mg/ml - protein c - protein c - restoration and maintenance of circulating blood volume where volume deficiency has been demonstrated and use of a colloid is appropriate. the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendation.

إسرائيل - العبرية - Ministry of Health

kamada ltd, israel - factor ix - אבקה להכנת תמיסה לזריקה - factor ix 1000 iu/vial - coagulation factor ix, ii, vii and x in combination - coagulation factor ix, ii, vii and x in combination - treatment and prophylaxis of bleeding in patients with haemophilia b ( congenital factor ix deficiency).

إسرائيل - العبرية - Ministry of Health

kamada ltd, israel - human plasma coagulation factor viii - אבקה להכנת תמיסה לזריקה - human plasma coagulation factor viii 50 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency. haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.

إسرائيل - العبرية - Ministry of Health

kamada ltd, israel - human plasma coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - human plasma coagulation factor viii 50 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency.haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.

إسرائيل - العبرية - Ministry of Health

kamada ltd, israel - human plasma coagulation factor viii - אבקה וממס להכנת תמיסה להזרקה - human plasma coagulation factor viii 100 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency.haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.

إسرائيل - العبرية - Ministry of Health

kamada ltd, israel - factor viii; von willebrand factor - אבקה להכנת תמיסה לזריקה - factor viii 500 iu/vial; von willebrand factor 1300 iu/vial - von willebrand factor and coagula-tion factor viii in combination - von willebrand factor and coagula-tion factor viii in combination - treatment and prophylaxis of bleeding with haemophilia a (congenital factor viii deficiency).

إسرائيل - العبرية - Ministry of Health

kamada ltd, israel - factor viii; von willebrand factor - אבקה להכנת תמיסה לזריקה - factor viii 1000 iu/vial; von willebrand factor 2600 iu/vial - von willebrand factor and coagula-tion factor viii in combination - von willebrand factor and coagula-tion factor viii in combination - treatment and prophylaxis of bleeding with haemophilia a (congenital factor viii deficiency).

إسرائيل - العبرية - Ministry of Health

kamada ltd, israel - albumin human - תמיסה לאינפוזיה - albumin human 45 mg/ml - albumin - albumin - for restoration and maintenance of circulation blood volume where volume deficiency has been demonstrated and use of a colloid, is appropriate.the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendations.

إسرائيل - العبرية - Ministry of Health

kamada ltd, israel - albumin human - תמיסה לאינפוזיה - albumin human 200 mg/ml - albumin - albumin - for restoration and maintenance of circulation blood volume where volume deficiency has been demonstrated and use of a colloid, is appropriate.the choice of albumin rather than artificial colloid will depend on the clinical situation of the individual patient, based on official recommendations.